| Name | Cbl-b-IN-12 |
|---|---|
| Synonyms | Imidazo[1,5-a]pyridin-3(2H)-one, 6-(5-azaspiroht-5-ylmethyl)-2-[3-[3-[(4-methyl-4H-1,2,4-triazol-3-yl)methyl]-3-oxetanyl]phenyl]-8-(trifluoromethyl) |
| Description | Cbl-b-IN-12 (Example 10) is a casitas B-lineage lymphoma-b (CBL-B) inhibitor with an IC50 of <100 nM[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: <100 nM (CBL-B)[1] |
| References |
[1]. Yingzhi Bi, et al. Compounds, compositions and methods of treating cancer. Patent WO2022221704A1. |
| Molecular Formula | C28H29F3N6O2 |
|---|---|
| Molecular Weight | 538.56 |